Roffman Miller Associates Inc. PA Sells 8,134 Shares of Colgate-Palmolive (NYSE:CL)

Roffman Miller Associates Inc. PA cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 28.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,197 shares of the company’s stock after selling 8,134 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in Colgate-Palmolive were worth $1,610,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Morgan Stanley increased its stake in Colgate-Palmolive by 3.2% in the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after acquiring an additional 514,559 shares during the last quarter. Northern Trust Corp increased its stake in Colgate-Palmolive by 3.3% in the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock valued at $672,198,000 after acquiring an additional 305,862 shares during the last quarter. American Century Companies Inc. increased its stake in Colgate-Palmolive by 2.0% in the third quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock valued at $468,644,000 after acquiring an additional 127,805 shares during the last quarter. FMR LLC boosted its position in Colgate-Palmolive by 27.3% in the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after buying an additional 1,199,660 shares in the last quarter. Finally, Nordea Investment Management AB grew its stake in shares of Colgate-Palmolive by 10.1% during the third quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock worth $390,005,000 after buying an additional 500,916 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Up 1.9 %

Shares of NYSE CL traded up $1.70 during trading on Friday, hitting $90.99. 5,409,206 shares of the company traded hands, compared to its average volume of 4,580,873. The business’s fifty day moving average is $87.51 and its 200 day moving average is $81.30. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $92.25. The firm has a market capitalization of $74.79 billion, a price-to-earnings ratio of 32.59, a P/E/G ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the business earned $0.73 earnings per share. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is currently 71.94%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on CL shares. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. UBS Group upped their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research report on Monday, January 29th. Finally, TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 29,772 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the sale, the chief executive officer now owns 301,343 shares in the company, valued at approximately $25,330,892.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Noel R. Wallace sold 29,772 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the sale, the chief executive officer now owns 301,343 shares in the company, valued at approximately $25,330,892.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock worth $19,505,099 in the last quarter. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.